ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 33 filers reported holding ACORDA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $5,928,000 | +77.3% | 6,080,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $3,344,000 | -35.8% | 6,080,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $5,208,000 | -1.0% | 6,080,000 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $5,261,000 | -0.7% | 6,080,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $5,296,000 | +15.9% | 6,080,000 | 0.0% | 0.00% | +100.0% |
| Q4 2019 | $4,570,000 | -3.9% | 6,080,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $4,757,000 | -6.8% | 6,080,000 | +1.3% | 0.00% | 0.0% |
| Q2 2019 | $5,104,000 | +163.8% | 6,000,000 | +199.7% | 0.00% | 0.0% |
| Q2 2018 | $1,935,000 | +23.8% | 2,002,000 | -2.7% | 0.00% | – |
| Q4 2016 | $1,563,000 | -17.0% | 2,057,000 | -10.8% | 0.00% | -100.0% |
| Q3 2016 | $1,882,000 | +10970.6% | 2,307,000 | +12042.1% | 0.00% | – |
| Q1 2016 | $17,000 | -99.7% | 19,000 | -99.6% | 0.00% | -100.0% |
| Q4 2014 | $4,927,000 | -13.6% | 4,282,000 | -22.1% | 0.00% | 0.0% |
| Q3 2014 | $5,701,000 | – | 5,495,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 15,510,000 | $16,119,000 | 3.21% |
| GRACE BROTHERS MANAGEMENT LLC | 2,500,000 | $2,592,000 | 2.44% |
| Mohican Financial Management, LLC | 3,000,000 | $3,113,000 | 1.52% |
| Wellesley Asset Management | 20,902 | $21,872,000 | 1.36% |
| Fore Research & Management, LP | 31,595,000 | $32,937,000 | 0.97% |
| Man Investments (CH) AG | 1,700,000 | $1,787,000 | 0.93% |
| SYMPHONY ASSET MANAGEMENT LLC | 7,834,000 | $8,128,000 | 0.84% |
| BASSO CAPITAL MANAGEMENT, L.P. | 5,000,000 | $5,150,000 | 0.79% |
| Baker Brothers Advisors | 60,000,000 | $62,050,000 | 0.78% |
| CAMDEN ASSET MANAGEMENT L P /CA | 10,225,000 | $10,608,000 | 0.44% |